Jim Simons Bluejay Diagnostics, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.19 - $0.41 $2,394 - $5,166
12,600 Added 34.52%
49,100 $13,000
Q1 2023

May 12, 2023
SELL
$0.38 - $0.87 $11,130 - $25,483
-29,291 Reduced 44.52%
36,500 $15,000
Q4 2022

Feb 13, 2023
BUY
$0.34 - $138.99 $5,504 - $2.25 Million
16,191 Added 32.64%
65,791 $25,000
Q3 2022

Nov 14, 2022
SELL
$0.83 - $132.53 $747 - $119,409
-901 Reduced 1.78%
49,600 $39,000
Q2 2022

Aug 12, 2022
BUY
$0.94 - $1.63 $47,470 - $82,316
50,501 New
50,501 $54,000

About Bluejay Diagnostics, Inc.

BJDX Quotes by TradingView
  • Ticker BJDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,152,300
  • Market Cap $75.6M
  • Description
  • Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...
More about BJDX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email